Open AccessThe Anti-Influenza Virus Drug Favipiravir Has Little Effect on Replication of SARS-CoV-2 in Cultured Cells
Author(s) -
Yuriko Tomita,
Makoto Takeda,
Shutoku Matsuyama
Publication year - 2021
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.00020-21
Subject(s) - favipiravir , virology , virus , context (archaeology) , antiviral drug , drug , viral replication , medicine , orthomyxoviridae , influenza a virus , covid-19 , biology , microbiology and biotechnology , pharmacology , infectious disease (medical specialty) , disease , paleontology